RekrutujeFaza III
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal…
Miasta: Gdańsk, Kraków, ŁódźWiek: od 18 latSponsor: Merck Healthcare KGaA
RekrutujeFaza III
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Miasta: Kraków, Kraków, Poznań, Szczecin i 3 inne miastaWiek: od 18 latSponsor: Merck Healthcare KGaA
RekrutujeFaza III
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Miasta: Bytom, Kraków, Lublin, Malbork i 3 inne miastaWiek: od 18 latSponsor: Merck Healthcare KGaA
RekrutujeFaza III
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Miasta: Gdańsk, Kraków, Warszawa, ZabrzeWiek: od 18 latSponsor: Merck Healthcare KGaA
Rekrutacja wkrótceFaza I
Phase 1b Multiple Ascending Doses (MAD) of M5542 in Patients
Miasta: Józefów, Rzeszów, WarszawaWiek: od 18 latSponsor: Merck Healthcare KGaA